277 related articles for article (PubMed ID: 24438336)
61. [Management of Toxoplasmic Seroconversion in the Third Trimester of Pregnancy in Tunisia].
Bouhlel S; Ben Abdallah R; Aoun K; Maatoug R; Souissi O; Bouratbine A
Bull Soc Pathol Exot; 2018; 111(5):269-274. PubMed ID: 30950590
[TBL] [Abstract][Full Text] [Related]
62. Results of a preventive program for congenital toxoplasmosis.
Ghidini A; Sirtori M; Spelta A; Vergani P
J Reprod Med; 1991 Apr; 36(4):270-3. PubMed ID: 2072359
[TBL] [Abstract][Full Text] [Related]
63. Incidence of congenital toxoplasmosis among infants born to HIV-coinfected mothers: case series and literature review.
Campos FA; Andrade GM; Lanna Ade P; Lage BF; Assumpção MV; Pinto JA
Braz J Infect Dis; 2014; 18(6):609-17. PubMed ID: 25017666
[TBL] [Abstract][Full Text] [Related]
64. [Congenital toxoplasmosis and seroconversion at the end of pregnancy: clinical observations].
Luyasu V; Bauraind O; Bernard P; Bietlot Y; Brasseur C; Englebert J; Fiasse L; Givron O; Longueville E; Melard JL; Michel M; Wacquez M
Acta Clin Belg; 1997; 52(6):381-7. PubMed ID: 9489134
[TBL] [Abstract][Full Text] [Related]
65. Association between the risk of congenital toxoplasmosis and the classification of toxoplasmosis in pregnant women and prenatal treatment in Brazil, 1994-2009.
Campello Porto L; Duarte EC
Int J Infect Dis; 2012 Jul; 16(7):e480-6. PubMed ID: 22522069
[TBL] [Abstract][Full Text] [Related]
66. Association between lymphadenopathy after toxoplasmosis seroconversion in pregnancy and risk of congenital infection.
Donadono V; Saccone G; Sarno L; Esposito G; Mazzarelli LL; Sirico A; Guida M; Martinelli P; Zullo F; Maruotti GM
Eur J Clin Microbiol Infect Dis; 2022 Jan; 41(1):45-51. PubMed ID: 34458947
[TBL] [Abstract][Full Text] [Related]
67. [Diagnosis, treatment and prevention of Toxoplasma infection during pregnancy].
Xue CL
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000; 18(1):55-7. PubMed ID: 12567480
[No Abstract] [Full Text] [Related]
68. Toxoplasmosis in pregnant women in Sanliurfa, Southeastern Anatolia City, Turkey.
Harma M; Harma M; Gungen N; Demir N
J Egypt Soc Parasitol; 2004 Aug; 34(2):519-25. PubMed ID: 15287175
[TBL] [Abstract][Full Text] [Related]
69. [Recall of the importance of serological monitoring of children with suspected congenital toxoplasmosis].
Pujol M; Malbruny B; Morel C; Exmelin L
Pathol Biol (Paris); 1992 Mar; 40(3):238-41. PubMed ID: 1608667
[TBL] [Abstract][Full Text] [Related]
70. Ecological comparison of the risks of mother-to-child transmission and clinical manifestations of congenital toxoplasmosis according to prenatal treatment protocol.
Gilbert R; Dunn D; Wallon M; Hayde M; Prusa A; Lebech M; Kortbeek T; Peyron F; Pollak A; Petersen E
Epidemiol Infect; 2001 Aug; 127(1):113-20. PubMed ID: 11561963
[TBL] [Abstract][Full Text] [Related]
71. Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis.
Gras L; Gilbert RE; Ades AE; Dunn DT
Int J Epidemiol; 2001 Dec; 30(6):1309-13. PubMed ID: 11821335
[TBL] [Abstract][Full Text] [Related]
72. [The prevalence of Toxoplasma gondii infection among 2016 pregnant women and their children in the Institute of Mother and Child in Warsaw].
Niemiec KT; Raczyński P; Markiewicz K; Leibschang J; Ceran A
Wiad Parazytol; 2002; 48(3):293-9. PubMed ID: 16888975
[TBL] [Abstract][Full Text] [Related]
73. Unresolved questions about the most successful known parasite.
Ajzenberg D
Expert Rev Anti Infect Ther; 2011 Feb; 9(2):169-71. PubMed ID: 21342063
[TBL] [Abstract][Full Text] [Related]
74. Prevention of congenital toxoplasmosis in Szeged, Hungary.
Szénási Z; Ozsvár Z; Nagy E; Jeszenszky M; Szabó J; Gellén J; Végh M; Verhofstede C
Int J Epidemiol; 1997 Apr; 26(2):428-35. PubMed ID: 9169181
[TBL] [Abstract][Full Text] [Related]
75. Toxoplasmosis screening and risk factors amongst pregnant females in Natal, northeastern Brazil.
Barbosa IR; de Carvalho Xavier Holanda CM; de Andrade-Neto VF
Trans R Soc Trop Med Hyg; 2009 Apr; 103(4):377-82. PubMed ID: 19211119
[TBL] [Abstract][Full Text] [Related]
76. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year.
Foulon W; Villena I; Stray-Pedersen B; Decoster A; Lappalainen M; Pinon JM; Jenum PA; Hedman K; Naessens A
Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):410-5. PubMed ID: 9988811
[TBL] [Abstract][Full Text] [Related]
77. Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy.
Wallon M; Liou C; Garner P; Peyron F
BMJ; 1999 Jun; 318(7197):1511-4. PubMed ID: 10356003
[TBL] [Abstract][Full Text] [Related]
78. Diagnosis of congenital toxoplasmosis: pre- and post-natal evaluation in Sicilian (Italy) epidemiological area. Preliminary data.
Di Carlo P; Casuccio A; La Chiusa S; Mazzola A; Pampinella D; Romano A; Schimmenti MG; Titone L; Mancuso G
Parassitologia; 2007 Jun; 49(1-2):39-41. PubMed ID: 18416004
[TBL] [Abstract][Full Text] [Related]
79. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling.
Dunn D; Wallon M; Peyron F; Petersen E; Peckham C; Gilbert R
Lancet; 1999 May; 353(9167):1829-33. PubMed ID: 10359407
[TBL] [Abstract][Full Text] [Related]
80. Azithromycin inhibits vertical transmission of Toxoplasma gondii in Calomys callosus (Rodentia: Cricetidae).
Costa IN; Angeloni MB; Santana LA; Barbosa BF; Silva MC; Rodrigues AA; Rostkowsa C; Magalhães PM; Pena JD; Silva DA; Mineo JR; Ferro EA
Placenta; 2009 Oct; 30(10):884-90. PubMed ID: 19703714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
